Evidence map›Paper›PMID 40828748›Full record

ArticlePloS one2025

Factors associated with time until metastatic spread in patients with primary uveal melanoma: A retrospective analysis.

Reinhard Told, Adrian Reumueller, Judith Kreminger, Stefan Sacu, Roman Dunavoelgyi

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Reinhard ToldDepartment of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0003-2046-7081
Adrian ReumuellerDepartment of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.
Judith KremingerDepartment of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0002-1548-3629
Stefan SacuDepartment of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.
Roman DunavoelgyiDepartment of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo characterize patients with choroidal or ciliary body (CB) melanoma in order to identify factors associated with time until metastasis and further perform a detailed characterization of the factors identified.

methodsA mixed model approach was used to identify parameters and patient characteristics associated with time until metastatic event. Consequently, the identified parameters were characterized.

resultsIn 383 patients with primary choroidal and CB melanoma, tumor thickness and patient age at diagnosis are associated with time until metastatic event. Mean patient age was 61 ± 13 years, mean choroidal and CB melanoma thickness was 5.1 ± 1.9 mm. Other factors investigated comprising sex, primary tumor width, length, volume, shape, and type of therapy are not associated with time until metastatic event in this patient collective.

conclusionIn conclusion, this study expands the current knowledge on factors associated with metastasis due to primary choroidal or CB melanoma. So far primary choroidal or CB melanoma thickness has been shown to be a risk indicator for metastatic events. Now, we could show that primary choroidal or CB melanoma thickness is also correlated with time until metastatic event. The association can be expressed as: the thicker the primary tumor, the earlier the potential metastatic event. Age may be considered an indirect effect in the model calculated.

Indexed as

Choroid NeoplasmsMelanomaUveal NeoplasmsAdultAgedAged, 80 and overCiliary BodyFemaleHumansMaleMiddle AgedNeoplasm MetastasisRetrospective StudiesRisk FactorsTime FactorsUveal Melanoma

Identifiers

PMID40828748
PMCPMC12364332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.